Rigel Pharmaceuticals

Rigel Pharmaceuticals Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and commercializing novel small molecule drugs that significantly improve the lives of patients with hematologic disorders, cancer, and rare immune diseases. The company's first FDA-approved product is TAVALISSE® (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The product is also commercially available in Europe (TAVLESSE), the United Kingdom, and Canada (TAVALISSE) for the treatment of chronic immune thrombocytopenia in adult patients. Fostamatinib is currently being studied in a Phase 3 clinical trial (NCT03764618) for the treatment of warm autoimmune hemolytic anemia (wAIHA)1; a Phase 3 clinical trial (NCT04629703) for the treatment of hospitalized high-risk patients with mild-to-moderate COVID-191; an NIH/NHLBI-funded Phase 3 ACTIV-4 Host Tissue Study (NCT04924660) for the treatment of COVID-19 in hospitalized patients on oxygen therapy, and a Phase 2 clinical trial (NCT04581954) for the treatment of COVID-19 being conducted by Imperial College London. Rigel's other clinical programs include its interleukin receptor-associated kinase (IRAK) inhibitor program, and a receptor-interacting serine/threonine-protein kinase (RIPK) inhibitor program in clinical development with partner Eli Lilly and Company. In addition, Rigel has product candidates in development with partners BerGenBio ASA and Daiichi Sankyo. For further information, visit www.rigel.com or follow us on Twitter or LinkedIn.

September is Month, and Rigel is supporting the ITP community and the Platelet Disorder Support Association. Join us i...
09/02/2025

September is Month, and Rigel is supporting the ITP community and the Platelet Disorder Support Association. Join us in helping to drive ITP awareness all month long.

This month Rigel celebrates pride, love, and equality. Diversity is strength, and together we are stronger.
06/02/2025

This month Rigel celebrates pride, love, and equality. Diversity is strength, and together we are stronger.

2025 is underway! To learn more about $RIGL and the company's hematology and oncology portfolio, come visit Booth #141...
05/31/2025

2025 is underway! To learn more about $RIGL and the company's hematology and oncology portfolio, come visit Booth #14131 during

Imagine a gender equal world. A world free of bias, stereotypes, and discrimination. March 8th is International Women’s ...
03/07/2025

Imagine a gender equal world. A world free of bias, stereotypes, and discrimination. March 8th is International Women’s Day – a day to celebrate women's achievement, raise awareness and take action to forge gender parity. Learn more about International Women’s Day at: https://www.internationalwomensday.com/

FREE International Women's Day 2025 theme resources -

On we recognize our Rigel employees and their commitment to living our Values. Rigel’s success is due to your contribu...
03/07/2025

On we recognize our Rigel employees and their commitment to living our Values. Rigel’s success is due to your contributions and teamwork. We are ONE! Thank you!

September is Month, and Rigel is supporting the ITP community and . Join us in promoting awareness all month long. p...
09/02/2024

September is Month, and Rigel is supporting the ITP community and . Join us in promoting awareness all month long. protectyourplatelets.com

Address

611 Gateway Boulevard, Suite 900
South San Francisco, CA
94080

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+16506241100

Website

Alerts

Be the first to know and let us send you an email when Rigel Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rigel Pharmaceuticals:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram